PACIFIC Study in Unresectable NSCLC

PACIFIC Study in Unresectable NSCLC
Don Photo

Don
3 years 186 Views
Category:
Description:
Dr. Kristin Higgins, MD, Associate Professor, Department of Radiation ONcology, Winship Cancer Institute of Emory University Medical Director, The Emory Clinic provides her interpretation of the data presented at ASCO 2019 from the PACIFIC Study investigating durvalumab in stage 3 unresectable non-small cell lung cancer (NSCLC).